Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Co-Spinal Ondansetron In Inguinal Herniorrhaphy
Sponsor: Suez Canal University
Summary
Ondansetron, a selective serotonin 5-HT3 receptor antagonist, is well known for its antiemetic effects. However, its ability to reduce hypotension during spinal anesthesia has recently sparked great interest. In clinical practice, administering ondansetron before spinal anesthesia has produced promising results.
Official title: The Efficacy of Co-Spinal Ondansetron In Inguinal Herniorrhaphy: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
46
Start Date
2025-03-15
Completion Date
2025-08-15
Last Updated
2025-04-30
Healthy Volunteers
No
Conditions
Interventions
Ondansetron 8mg
Patients will receive 8 mg of ondansetron (ZOFATRONE®, 8 mg/4 mL, EVA Pharma, Egypt)
Normal Saline
Patients will be managed by administering 100 ml of normal saline solution as placebo
Locations (1)
Suez Canal University
Ismailia, Egypt